ConductScience.org, home

Trial · NCT02135848

Results by group192

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)GSK1278863 300 mgAE14Participants
Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)Placebo Matched With GSK1278863 300 mgAE6Participants
Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)GSK1278863 15 mgAE9Participants
Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)Placebo Matched With GSK1278863 15 mgAE3Participants
Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)GSK1278863 300 mgSAE2Participants
Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)Placebo Matched With GSK1278863 300 mgSAE0Participants
Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)GSK1278863 15 mgSAE0Participants
Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE)Placebo Matched With GSK1278863 15 mgSAE1Participants
Number of Participants With Abnormal Electrocardiogram (ECG) FindingsGSK1278863 300 mgAcute Day 1, Pre-dose; Abnormal NCS14Participants
Number of Participants With Abnormal Electrocardiogram (ECG) FindingsPlacebo Matched With GSK1278863 300 mgAcute Day 1, Pre-dose; Abnormal NCS16Participants
Number of Participants With Abnormal Electrocardiogram (ECG) FindingsGSK1278863 300 mgAcute Day 1, Pre-dose; Abnormal CS0Participants
Number of Participants With Abnormal Electrocardiogram (ECG) FindingsPlacebo Matched With GSK1278863 300 mgAcute Day 1, Pre-dose; Abnormal CS0Participants
Number of Participants With Abnormal Electrocardiogram (ECG) FindingsGSK1278863 300 mgAcute Day 1, 2.5 hour; Abnormal NCS15Participants
Number of Participants With Abnormal Electrocardiogram (ECG) FindingsPlacebo Matched With GSK1278863 300 mgAcute Day 1, 2.5 hour; Abnormal NCS14Participants
Number of Participants With Abnormal Electrocardiogram (ECG) FindingsGSK1278863 300 mgAcute Day 1, 2.5 hour; Abnormal CS0Participants
Number of Participants With Abnormal Electrocardiogram (ECG) FindingsPlacebo Matched With GSK1278863 300 mgAcute Day 1, 2.5 hour; Abnormal CS0Participants
Number of Participants With Abnormal Electrocardiogram (ECG) FindingsGSK1278863 15 mgChronic Day 1, Pre-dose; Abnormal NCS12Participants
Number of Participants With Abnormal Electrocardiogram (ECG) FindingsPlacebo Matched With GSK1278863 15 mgChronic Day 1, Pre-dose; Abnormal NCS14Participants
Number of Participants With Abnormal Electrocardiogram (ECG) FindingsGSK1278863 15 mgChronic Day 1, Pre-dose; Abnormal CS0Participants
Number of Participants With Abnormal Electrocardiogram (ECG) FindingsPlacebo Matched With GSK1278863 15 mgChronic Day 1, Pre-dose; Abnormal CS0Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02135848/results